Sept4 has been shown to attenuate alpha-synuclein neurotoxicity in the brain of a PD mouse model, and to be required for dopaminergic neurons to maintain key components of dopamine metabolism 29. This evidence concerns the gene SEPTIN4 and Parkinson disease.